* OptiNose Inc OPTN.OQ reported a quarterly adjusted loss
of 9
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -17
cents. The mean expectation of three analysts for the quarter
was for a loss of 9 cents per share. Wall Street expected
results to range from -10 cents to -9 cents per share.
* Revenue fell 4.8% to $19.87 million from a year ago;
analysts
expected $19.23 million.
* OptiNose Inc's reported EPS for the quarter was a loss
of 9
cents.
* The company reported a quarterly loss of $9.97 million.
* OptiNose Inc shares had risen by 35.7% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for OptiNose
Inc is
$3.00
This summary was machine generated from LSEG data March 7 at
02:30 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.09 -0.09 Met
Sep. 30 2023 -0.09 -0.08 Beat
Jun. 30 2023 -0.11 0.02 Beat
Mar. 31 2023 -0.14 -0.17 Missed